| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.086 | 0.09 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.1 |